A First-in-Human Study of FLX475 in Healthy Volunteers
Recruiting
- Conditions
- Healthy human volunteers (preliminary safety study)Cancer
- Registration Number
- NL-OMON26146
- Lead Sponsor
- FLX Bio, Inc.PRA Health Sciences located at Van Swietenlaan 6, 9728 NZ Groningen, in The Netherlands.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 104
Inclusion Criteria
Healthy Male or Female
18-55 years of age, inclusive
Exclusion Criteria
Use of tobacco products within 60 days prior to drug administration
History of alcohol abuse or drug addiction
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety and tolerability of single and multiple oral ascending doses of FLX475 administered to healthy male and female subjects
- Secondary Outcome Measures
Name Time Method Pharmacokinetics of FLX475 (capsule and tablet formulation)<br>Food effect